CD30 Recombinant Rabbit mAb (SDT-216-2)

產(chǎn)品型號(hào)：S0B2183

更新時(shí)間：2025-10-09

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：148

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

重組兔單抗能否成為下一代抗體技術(shù)的前沿者？

促紅細(xì)胞生成素：其生理機(jī)制與臨床應(yīng)用知多少？

外泌體介導(dǎo)的IFN-α抗HBV效應(yīng)傳遞機(jī)制研究

產(chǎn)品介紹

CD30 is a transmembrane protein from the tumour necrosis factor receptor superfamily. It is expressed on a small subset of activated T and B lymphocytes, and various lymphoid neoplasms. CD30 is a particularly treatment target because its levels are high in tumours but low in healthy tissues. Several therapeutic strategies targeting CD30 have been developed, including monoclonal antibodies, conjugated antibodies （combination of brentuximab vedotin with chemotherapy or immunotherapy）, bispecific antibodies and cell and gene therapies, such as anti-CD30 CAR-T cells in particular [PMID: 37170397

].

上一個(gè)：S0B2182SOX9 Recombinant Rabbit mAb (SDT-019-29)